DanaZakalikMD

Oncology • Royal Oak, MI

Breast Cancer, Cancer Genetics/Cancer Risk Assessment, Hematologic Oncology

Professor of Medicine, Oakland University-William Beaumont Medical School

Join to view full profile

Dr. Zakalik is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Zakalik's full profile

Already have an account?

Office
3577 W 13 Mile Rd
Ste 140
Royal Oak, MI 48073
Phone+1 248-551-3388

Fax+1 248-551-8437

Education & Training

University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1988 - 1991
University of MichiganResidency, Internal Medicine, 1983 - 1986
University of Michigan Medical SchoolClass of 1983

Certifications & Licensure

CA State Medical License 1989 - Present
MI State Medical License 1985 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook

Publications & Presentations

PubMed

69 citations
Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin‐induced thrombocytopenia
Maureen A. Smythe, Theodore E. Warkentin, Jennifer L. Stephens, Dana Zakalik, Joan C. Mattson
American Journal of Hematology. 2002-09-01
55 citations
Male BRCA mutation carriers: clinical characteristics and cancer spectrum.
Mohammed Ibrahim, Siddhartha Yadav, Foluso Ogunleye, Dana Zakalik
BMC Cancer. 2018-02-13
27 citations
Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
Jacek Gronwald, André Robidoux, Charmaine Kim-Sing, Nadine Tung, Henry T. Lynch
Breast Cancer Research and Treatment. 2014-06-21

Lectures

Clinical Outcome Following Reinstitution of Anticoagulation after Major Gastrointestinal Bleed: A Single Institutional Analysis
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Dr. Dana Zakalik ~ WJR Late MorningsJune 7th, 2021
Beaumont Seeking Cancer Patients with COVID-19 for National StudyAugust 20th, 2020
Beaumont Looking for Cancer Patients with COVID-19 for New National StudyAugust 20th, 2020
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member